ATAI Life Sciences
Price & Volume
Stats
See moreOpen | $4.41 |
Previous Close | $4.41 |
Day Range | $4.41-$4.54 |
52W Range | $2-$6.75 |
Market Cap | $1.5B |
Shares Short | 23M |
Financials
See moreRevenue (12 Mos) | $3.4M |
Revenue Growth (YoY) | -38.7% |
Gross Profit (12 Mos) | -$44.1M |
Diluted EPS | -$2.84 |
News
See moreYahoo Finance • 18 days ago
AtaiBeckley targets Q2 start for Phase 3 depression trial as pipeline advances
Yahoo Finance • last month
Jefferies analyst says Trump's executive order on psychedelics is an 'official stamp of validation' for investors
Yahoo Finance • last month
AtaiBeckley's EMP-01 Shows Large And Consistent Improvements In Social Anxiety Disorder
Yahoo Finance • last month
What’s Guggenheim Updates View on AtaiBeckley Inc (ATAI)?
About
CEO | Dr. Srinivas G. Rao M.D., Ph.D. |
Address | 250 West 34th Street, New York, NY, United States, 10119 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 99 |